LUNGevity's September Newsletter
LUNGevity funds the future of lung cancer researchers
We’re excited to announce the recipients of our 2020 Career Development Awards (CDA) for lung cancer research. These awards fund critical lung cancer research projects and offer the recipients mentoring by LUNGevity’s distinguished Scientific Advisory Board. We are proud to support the following biomarker-driven 2020 CDA researchers and their projects.
Kathryn Arbour, MD
Memorial Sloan Kettering Cancer Center; Mechanisms of resistance to direct KRAS G12C inhibition
Carl Gay, MD, PhD
MD Anderson Cancer Center; SCLC molecular subtypes to predict targeted and immune therapy response
Sean Pitroda, MD
University of Chicago; Predictive biomarkers of radio-immunotherapeutic response in NSCLC.
Learn more about these researchers’ projects and their impact in our press release and more about the CDA program on our website. You can also support LUNGevity research.
LUNGevity launches Project PEER in collaboration with the FDA
LUNGevity is proud to collaborate with the FDA to better understand the lung cancer patient experience. Project PEER, or Understanding the lung cancer Patient ExperiEnce in the Real-world setting, is a multi-year study that seeks to systematically understand how patients with lung cancer feel and function and whether this experience is affected by their specific diagnosis and treatment.
The real-world data from Project PEER will be used to explore patterns in patient experiences and compare those patterns to what is seen in clinical trial data within the same patient population. Project PEER also provides the FDA real-world data about how our patient population, particularly those underrepresented in clinical trials, respond to therapies. Our collaboration with the FDA has the potential to make an impact on the future of treatment for lung cancer, resulting in better outcomes for patients.
Learn more about the new study in the press release. Patients and caregivers interested in participating may visit the study site to find out about eligibility and registration.
Sign up to help eRACE Lung Cancer
eRACE Lung Cancer, LUNGevity’s first-ever virtual race, brings together runners, walkers, and athletes from across the country with one common goal: to erase lung cancer. Participants will walk or run their own race and choose the distance, location, date, and time.
eRACE Lung Cancer will take place October 1 – October 17, 2020 with a virtual celebration on October 18.
Whether you’re a first-time runner or an accomplished marathoner, eRACE Lung Cancer has something for you. This is a great opportunity to challenge yourself, try something new, and stay motivated through the uncertainties of COVID-19 while supporting our lung cancer community and connecting with others. Grab your friends, family, or co-workers and start a team or participate solo.
Learn more about the event here.
Save the dates for our other fall virtual events!
Breathe Deep TOGETHER
Join us again on October 24th for Breathe Deep TOGETHER, a virtual broadcast of celebration, hope, and remembrance for all those affected by lung cancer, followed by a walk in your own neighborhood.
Lung health and research are more important than ever and together we can continue to make a difference in the lung cancer community.
If you register and make a $25 self-donation by October 1st, you will receive a Breathe Deep TOGETHER gaiter before the event on October 24th. Register today!
Celebration of Hope
The Celebration of Hope has a new twist. Join LUNGevity for an entertaining virtual event to celebrate and support the hope and progress of lung cancer research.
Event highlights include the presentation of the Face of Hope Awards and the Face of Hope Award for Corporate Leadership.
The virtual event will stream Wednesday, October 21st at 4:30 PM EDT.
